GAMMA PHARMACEUTICAL (GREY:GMPM)

On September 13, 2011, shareholders holding 52.04% of the outstanding shares of common stock of Gamma Pharmaceuticals Inc. (“Gamma”) removed Hao Zhang from Gamma’s Board of Directors. The removal did not result from any disagreement between Hao Zheng and the other Directors of the company. Rather, Hao Zhang had been inactive as a Director of Gamma for some time as a result of Gamma’s deferral of plans to enter the Chinese market.

On February 18, 2010, Gamma Pharmaceuticals, Inc. (“Gamma” or the “Company”) entered into an agreement to form a Joint Venture Company named Holyfield Gamma Choice, LLC (“HGC”) with Holyfield International, LLC, an entity affiliated with Boxing World Heavyweight Champion, Evander Holyfield. Mr. Holyfield is the only 4-time Boxing World Heavyweight Champion and, in unaided focus groups, he is identified as one of the world’s most recognized athletes. The joint venture, branded “Holyfield Choice,” is formulating and marketing an exclusive line of vitamins and nutritional products utilizing Mr. Holyfield’s expertise in nutrition and physical training and Gamma’s formulation and marketing knowhow. HGC is closely integrated with Gamma’s existing corporate infrastructure and distribution channels, and currently has four product lines and seven SKUs, with plans for expansion. Under the terms of the joint venture, Gamma will consolidate HGC’s performance into Gamma’s financials.

On February 23, 2010, Gamma entered into a multi-year agreement with Wholesale Depot Corp. ("WDC"), one of North America’s leading wholesale distribution organizations to distribute the full line of Gamma products. The agreement, which is evergreen in duration, provides for minimum monthly volume purchases at wholesale of 40,000 cases of Gamma’s various branded products once product and distribution levels are ramped up to the contract minimums. Gamma and WDC are diligently working together to achieve these minimum levels as soon as possible.

Source: 8K filing (February 18, 2010)

We have entered into a long-term, minimum purchase contract with a leading U.S. distribution partner to market and distribute Gamma products, with contractual minimum set to achieve annualized sales of approximately $48 million.

Source: Marketwire (February 25, 2010)